KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$503.0 million.

  • AbbVie's Other Non Operating Income rose 5660.05% to -$503.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.7 billion, marking a year-over-year decrease of 187.26%. This contributed to the annual value of -$3.2 billion for FY2024, which is 3072.48% up from last year.
  • Per AbbVie's latest filing, its Other Non Operating Income stood at -$503.0 million for Q3 2025, which was up 5660.05% from -$2.6 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Other Non Operating Income ranged from a high of $776.0 million in Q1 2022 and a low of -$2.7 billion during Q2 2021
  • Over the past 5 years, AbbVie's median Other Non Operating Income value was -$1.2 billion (recorded in 2024), while the average stood at -$918.3 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 167142.86% in 2022, then plummeted by 132000.0% in 2024.
  • Quarter analysis of 5 years shows AbbVie's Other Non Operating Income stood at -$216.0 million in 2021, then tumbled by 835.65% to -$2.0 billion in 2022, then rose by 23.01% to -$1.6 billion in 2023, then skyrocketed by 90.36% to -$150.0 million in 2024, then tumbled by 235.33% to -$503.0 million in 2025.
  • Its Other Non Operating Income was -$503.0 million in Q3 2025, compared to -$2.6 billion in Q2 2025 and -$1.4 billion in Q1 2025.